Raquel Rivera-Díaz

26PUBLICATIONS
57CO-AUTHORS
Nanotoxicology, health and safetyMultimorbidityRheumatology and arthritisPharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|Apr 18, 2026
Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.

|Mar 02, 2026
Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis.

R Queiro-Silva, A López-Ferrer, M Ferran I Farrés

|May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

María Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig

|Apr 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Juan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada

|Dec 28, 2023
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

E Muñoz-Aceituno, B Butrón-Bris, M C Ovejero-Benito

Pageof 5

Frequent Collaborators

11 joint publications

Mar Llamas-Velasco

8 joint publications

José Manuel Carrascosa

7 joint publications

Isabel Belinchón-Romero

6 joint publications

Pablo de la Cueva